top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Career options in the pharmaceutical and biomedical industry : an insider's guide / / Josse R. Thomas, Luciano Saso, Chris F.H. van Schravendijk, editors
Career options in the pharmaceutical and biomedical industry : an insider's guide / / Josse R. Thomas, Luciano Saso, Chris F.H. van Schravendijk, editors
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2023]
Descrizione fisica 1 online resource (334 pages)
Disciplina 338.476606
Soggetto topico Biotechnology industries
Biotechnology industries - Vocational guidance
Pharmaceutical industry - Vocational guidance
ISBN 3-031-14911-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part 1: Setting the scene -- Chapter 1: Life after Academia: Launching your Pharma/Biotech Career -- Chapter 2: Competences for Pharmacists -- Chapter 3: Job and Career Opportunities in the Pharmaceutical Industry: An Overview -- Part 2: Opportunities along the drug/product life cycle -- Chapter 4: Career Opportunities in Toxicology -- Chapter 5: Job Possibilities in Clinical Research -- Chapter 6: How to Get and Develop a Career in a Market Access Role in the Medical Devices Industry -- Chapter 7: Job Opportunities in Pharmaceutical Marketing -- Chapter 8: Working in Medical Affairs and Clinical Operations: Life-Changing Careers -- Chapter 9: The Role of Medical Science Liaison -- Chapter 10: Career Development for Physicians in the Biopharmaceutical Industry -- Part 3: Opportunities in Supportive Functions -- Chapter 11: Job and Career Opportunities in Regulatory Affairs/Science -- Chapter 12: Job Opportunities in Clinical Research Quality Assurance -- Chapter 13: Job Opportunities in Quality Assurance Related to Manufacturing of Medicinal Products -- Part 4: Other Opportunities in the Pharmaceutical and Biomedical Sector -- Chapter 14: Careers Perspective in a Science and Technology Park -- Chapter 15: To be or not to be: Entrepreneurship and Enterprise Creation as a Way to Innovate in Life Sciences -- Chapter 16: How to Become a Successful Hospital and Community Pharmacist -- Part 5: Practical tips and tricks -- Chapter 17: A Successful Career in the Life Sciences Industry: How to Write your Strongest Resumé and Ace that Interview -- Chapter 18: Skill Building for Career Advancement: Public Speaking and Networking -- Chapter 19: Training Opportunities for a Career in the Pharmaceutical and Biomedical Industry/Sector.
Record Nr. UNINA-9910647777903321
Cham, Switzerland : , : Springer, , [2023]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
China's biotechnology development : the role of US and other foreign engagement : a report prepared for the U.S.-China Economic and Security Review Commission / / Mark Kazmierczak, Ph. D., Ryan Ritterson, Ph. D. Danielle Gardner, Rocco Casagrande, Ph. D., Thilo Hanamann, Daniel H. Rosen
China's biotechnology development : the role of US and other foreign engagement : a report prepared for the U.S.-China Economic and Security Review Commission / / Mark Kazmierczak, Ph. D., Ryan Ritterson, Ph. D. Danielle Gardner, Rocco Casagrande, Ph. D., Thilo Hanamann, Daniel H. Rosen
Autore Kazmierczak Mark
Pubbl/distr/stampa Takoma Park, Maryland : , : Gryphon Scientific
Descrizione fisica 1 online resource (ii, 148 pages) : color illustrations
Soggetto topico Biotechnology industries - China
Biotechnology industries - United States
Science and state - China
Investments, Chinese - United States
Intellectual property - Government policy - China
Investments, American - China
Biotechnology - Research - International cooperation
Biotechnology industries
Intellectual property - Government policy
Investments, American
Investments, Chinese
Science and state
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti China's biotechnology development
Record Nr. UNINA-9910715923003321
Kazmierczak Mark  
Takoma Park, Maryland : , : Gryphon Scientific
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Concentration and technology in agricultural input industries [[electronic resource] /] / John L. King
Concentration and technology in agricultural input industries [[electronic resource] /] / John L. King
Autore King John L
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Dept of Agriculture, , [2001]
Collana Agriculture information bulletin
Soggetto topico Agricultural biotechnology - Research
Biotechnology industries
Industrial concentration
Intellectual property
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Electronic report from the Economic Research Service
Record Nr. UNINA-9910692040903321
King John L  
[Washington, D.C.] : , : U.S. Dept of Agriculture, , [2001]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
Soggetto genere / forma Electronic books.
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910461624903321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910790277003321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi
Autore Mellon Jim
Pubbl/distr/stampa Chichester, West Sussex, U.K., : Wiley, 2012
Descrizione fisica 1 online resource (362 p.)
Disciplina 338.4/76151
Altri autori (Persone) ChalabiAl
Soggetto topico Biotechnology industries - Finance
Pharmaceutical industry - Finance
Biotechnology industries
Pharmaceutical industry
Investments
ISBN 1-119-96937-9
1-280-67915-8
9786613656087
1-119-96936-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease
ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home?
ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing
Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index
Record Nr. UNINA-9910825483003321
Mellon Jim  
Chichester, West Sussex, U.K., : Wiley, 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Darwin's medicine : how business models in the life sciences industry are evolving / / Brian D. Smith
Darwin's medicine : how business models in the life sciences industry are evolving / / Brian D. Smith
Autore Smith Brian D (Brian David), <1961-, >
Edizione [First edition.]
Pubbl/distr/stampa New York : , : Routledge, , 2017
Descrizione fisica 1 online resource (296 pages) : illustrations, tables
Disciplina 338.476151
Soggetto topico Pharmaceutical industry
Biotechnology industries
ISBN 1-315-57587-6
1-317-15471-1
1-317-15472-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto pt. 1. The future of pharma : reprise -- pt. 2. An immeasurably superior power -- pt. 3Evolution is cleverer than you are -- pt. 4. Guiding the blind watchmaker.
Record Nr. UNINA-9910136148503321
Smith Brian D (Brian David), <1961-, >  
New York : , : Routledge, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Autore Ramamohan Rao T. V. S
Pubbl/distr/stampa New Delhi, : New Age International (P) Ltd., Publishers, c2007
Descrizione fisica 1 online resource (198 p.)
Soggetto topico Biotechnology - Economic aspects
Biotechnology industries
Soggetto genere / forma Electronic books.
ISBN 1-282-07418-0
9786612074189
81-224-2638-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1 Introduction ""; ""1.1 Changing Technology ""; ""1.2 Modern Biotechnology ""; ""1.3 Organizational Issues ""; ""1.4 Patents and IPR's ""; ""1.5 Market Structure ""; ""1.6 Ethical and Environmental Concerns ""; ""1.7 Government Policy ""; ""1.8 Looking Ahead ""; ""Chapter 2 Organizational Structure ""; ""2.1 The Scope ""; ""2.2 Knowledge Intensity ""; ""2.3 Biotechnology Knowledge ""; ""2.4 Network Organization ""; ""2.5 Nature of Contracts ""; ""2.6 Sharing Fixed Costs ""; ""2.7 Economic Consequences ""; ""2.8 Other Aspects ""
""Chapter 3 IPRs and Patents """"3.1 Why Protection? ""; ""3.2 Patents as Protection ""; ""3.3 Biotechnology Patents ""; ""3.4 IPR Agreements ""; ""3.5 TRIPS Agreement ""; ""3.6 Consequences of Protection ""; ""3.7 Issues of Concern ""; ""3.8 Modifications to Patent Regime ""; ""Chapter 4 Investment and Financing ""; ""4.1 The Issues ""; ""4.2 Role of Public Investment ""; ""4.3 R&D in Scientific Knowledge ""; ""4.4 Risks of R&D ""; ""4.5 Complementary R&D ""; ""4.6 Agricultural Extension Services ""; ""4.7 Bioprocessing ""; ""4.8 Physical Capital ""; ""4.9 Financing Constraints ""
""4.10 Further Considerations """"Chapter 5 Demand, Cost and Productivity ""; ""5.1 The Background ""; ""5.2 Patterns of Demand ""; ""5.3 Productivity ""; ""5.4 Variable Costs ""; ""5.5 Welfare Effects ""; ""5.6 Summing Up ""; ""Chapter 6 Market Structure and Pricing ""; ""6.1 Nature of Markets ""; ""6.2 Defining Market Concentration ""; ""6.3 Sources of Concentration ""; ""6.4 Monopoly Power and Pricing ""; ""6.5 Differential Pricing ""; ""6.6 Dynamic Pricing ""; ""6.7 In Retrospect ""; ""Chapter 7 Ethics and Environment ""; ""7.1 Issues at Stake ""; ""7.2 Ethical Issues ""
""7.3 Environmental Issues """"7.4 Ethical Issues in Agricultural Biotechnology ""; ""7.5 Ethical Issues in Drug Development ""; ""7.6 Environmental Issues ""; ""7.7 International Conventions ""; ""7.8 Lessons and Control ""; ""Chapter 8 Government Policy ""; ""8.1 An Overview ""; ""8.2 Scientific R&D ""; ""8.3 Scientist vs. NBF Contract ""; ""Chapter 9 Conclusion ""; ""9.1 The Technology ""; ""9.2 Organizational Aspects ""; ""9.3 Product Profiles and Markets ""; ""9.4 Negative effects ""; ""9.5 Steady State ""; ""Appendices ""; ""Appendix 1 Technical Terms ""
""Appendix 2 Economic Concepts """"Appendix 3 Mathematical Background ""; ""References ""; ""Index ""
Record Nr. UNINA-9910454299603321
Ramamohan Rao T. V. S  
New Delhi, : New Age International (P) Ltd., Publishers, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Autore Ramamohan Rao T. V. S
Pubbl/distr/stampa New Delhi, : New Age International (P) Ltd., Publishers, c2007
Descrizione fisica 1 online resource (198 p.)
Soggetto topico Biotechnology - Economic aspects
Biotechnology industries
ISBN 1-282-07418-0
9786612074189
81-224-2638-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1 Introduction ""; ""1.1 Changing Technology ""; ""1.2 Modern Biotechnology ""; ""1.3 Organizational Issues ""; ""1.4 Patents and IPR's ""; ""1.5 Market Structure ""; ""1.6 Ethical and Environmental Concerns ""; ""1.7 Government Policy ""; ""1.8 Looking Ahead ""; ""Chapter 2 Organizational Structure ""; ""2.1 The Scope ""; ""2.2 Knowledge Intensity ""; ""2.3 Biotechnology Knowledge ""; ""2.4 Network Organization ""; ""2.5 Nature of Contracts ""; ""2.6 Sharing Fixed Costs ""; ""2.7 Economic Consequences ""; ""2.8 Other Aspects ""
""Chapter 3 IPRs and Patents """"3.1 Why Protection? ""; ""3.2 Patents as Protection ""; ""3.3 Biotechnology Patents ""; ""3.4 IPR Agreements ""; ""3.5 TRIPS Agreement ""; ""3.6 Consequences of Protection ""; ""3.7 Issues of Concern ""; ""3.8 Modifications to Patent Regime ""; ""Chapter 4 Investment and Financing ""; ""4.1 The Issues ""; ""4.2 Role of Public Investment ""; ""4.3 R&D in Scientific Knowledge ""; ""4.4 Risks of R&D ""; ""4.5 Complementary R&D ""; ""4.6 Agricultural Extension Services ""; ""4.7 Bioprocessing ""; ""4.8 Physical Capital ""; ""4.9 Financing Constraints ""
""4.10 Further Considerations """"Chapter 5 Demand, Cost and Productivity ""; ""5.1 The Background ""; ""5.2 Patterns of Demand ""; ""5.3 Productivity ""; ""5.4 Variable Costs ""; ""5.5 Welfare Effects ""; ""5.6 Summing Up ""; ""Chapter 6 Market Structure and Pricing ""; ""6.1 Nature of Markets ""; ""6.2 Defining Market Concentration ""; ""6.3 Sources of Concentration ""; ""6.4 Monopoly Power and Pricing ""; ""6.5 Differential Pricing ""; ""6.6 Dynamic Pricing ""; ""6.7 In Retrospect ""; ""Chapter 7 Ethics and Environment ""; ""7.1 Issues at Stake ""; ""7.2 Ethical Issues ""
""7.3 Environmental Issues """"7.4 Ethical Issues in Agricultural Biotechnology ""; ""7.5 Ethical Issues in Drug Development ""; ""7.6 Environmental Issues ""; ""7.7 International Conventions ""; ""7.8 Lessons and Control ""; ""Chapter 8 Government Policy ""; ""8.1 An Overview ""; ""8.2 Scientific R&D ""; ""8.3 Scientist vs. NBF Contract ""; ""Chapter 9 Conclusion ""; ""9.1 The Technology ""; ""9.2 Organizational Aspects ""; ""9.3 Product Profiles and Markets ""; ""9.4 Negative effects ""; ""9.5 Steady State ""; ""Appendices ""; ""Appendix 1 Technical Terms ""
""Appendix 2 Economic Concepts """"Appendix 3 Mathematical Background ""; ""References ""; ""Index ""
Record Nr. UNINA-9910777751503321
Ramamohan Rao T. V. S  
New Delhi, : New Age International (P) Ltd., Publishers, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Economics of biotechnology [[electronic resource] /] / T.V.S. Ramamohan Rao
Autore Ramamohan Rao T. V. S
Pubbl/distr/stampa New Delhi, : New Age International (P) Ltd., Publishers, c2007
Descrizione fisica 1 online resource (198 p.)
Soggetto topico Biotechnology - Economic aspects
Biotechnology industries
ISBN 1-282-07418-0
9786612074189
81-224-2638-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1 Introduction ""; ""1.1 Changing Technology ""; ""1.2 Modern Biotechnology ""; ""1.3 Organizational Issues ""; ""1.4 Patents and IPR's ""; ""1.5 Market Structure ""; ""1.6 Ethical and Environmental Concerns ""; ""1.7 Government Policy ""; ""1.8 Looking Ahead ""; ""Chapter 2 Organizational Structure ""; ""2.1 The Scope ""; ""2.2 Knowledge Intensity ""; ""2.3 Biotechnology Knowledge ""; ""2.4 Network Organization ""; ""2.5 Nature of Contracts ""; ""2.6 Sharing Fixed Costs ""; ""2.7 Economic Consequences ""; ""2.8 Other Aspects ""
""Chapter 3 IPRs and Patents """"3.1 Why Protection? ""; ""3.2 Patents as Protection ""; ""3.3 Biotechnology Patents ""; ""3.4 IPR Agreements ""; ""3.5 TRIPS Agreement ""; ""3.6 Consequences of Protection ""; ""3.7 Issues of Concern ""; ""3.8 Modifications to Patent Regime ""; ""Chapter 4 Investment and Financing ""; ""4.1 The Issues ""; ""4.2 Role of Public Investment ""; ""4.3 R&D in Scientific Knowledge ""; ""4.4 Risks of R&D ""; ""4.5 Complementary R&D ""; ""4.6 Agricultural Extension Services ""; ""4.7 Bioprocessing ""; ""4.8 Physical Capital ""; ""4.9 Financing Constraints ""
""4.10 Further Considerations """"Chapter 5 Demand, Cost and Productivity ""; ""5.1 The Background ""; ""5.2 Patterns of Demand ""; ""5.3 Productivity ""; ""5.4 Variable Costs ""; ""5.5 Welfare Effects ""; ""5.6 Summing Up ""; ""Chapter 6 Market Structure and Pricing ""; ""6.1 Nature of Markets ""; ""6.2 Defining Market Concentration ""; ""6.3 Sources of Concentration ""; ""6.4 Monopoly Power and Pricing ""; ""6.5 Differential Pricing ""; ""6.6 Dynamic Pricing ""; ""6.7 In Retrospect ""; ""Chapter 7 Ethics and Environment ""; ""7.1 Issues at Stake ""; ""7.2 Ethical Issues ""
""7.3 Environmental Issues """"7.4 Ethical Issues in Agricultural Biotechnology ""; ""7.5 Ethical Issues in Drug Development ""; ""7.6 Environmental Issues ""; ""7.7 International Conventions ""; ""7.8 Lessons and Control ""; ""Chapter 8 Government Policy ""; ""8.1 An Overview ""; ""8.2 Scientific R&D ""; ""8.3 Scientist vs. NBF Contract ""; ""Chapter 9 Conclusion ""; ""9.1 The Technology ""; ""9.2 Organizational Aspects ""; ""9.3 Product Profiles and Markets ""; ""9.4 Negative effects ""; ""9.5 Steady State ""; ""Appendices ""; ""Appendix 1 Technical Terms ""
""Appendix 2 Economic Concepts """"Appendix 3 Mathematical Background ""; ""References ""; ""Index ""
Record Nr. UNINA-9910816335403321
Ramamohan Rao T. V. S  
New Delhi, : New Age International (P) Ltd., Publishers, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui